Insider Trading
Track Major Insider Updates On X/Twitter
NUVL Stock Insider Trading Activity
Corporate insiders are required to disclose purchases or sales of their own stock within two business days of when they occur. Using these disclosures, we collect data on NUVL stock insider trading activity, which can give hints on whether Nuvalent Inc - Ordinary Shares - Class A executives are bullish or bearish on their own company.
Recent insider purchases and sales - NUVL
Name / Title | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
Porter James Richard
President and CEO
|
Sale | 488 | Apr 15, 2025 | April 17, 2025, 4:55 p.m. |
Porter James Richard
President and CEO
|
Sale | 4465 | Apr 15, 2025 | April 17, 2025, 4:55 p.m. |
Porter James Richard
President and CEO
|
Sale | 11060 | Apr 15, 2025 | April 17, 2025, 4:55 p.m. |
Porter James Richard
President and CEO
|
Sale | 10987 | Apr 15, 2025 | April 17, 2025, 4:55 p.m. |
Noci Darlene
Chief Development Officer
|
Sale | 900 | Mar 27, 2025 | March 28, 2025, 4:45 p.m. |
Noci Darlene
Chief Development Officer
|
Sale | 3100 | Mar 27, 2025 | March 28, 2025, 4:45 p.m. |
Porter James Richard
President and CEO
|
Sale | 16363 | Mar 17, 2025 | March 19, 2025, 4:47 p.m. |
Porter James Richard
President and CEO
|
Sale | 10036 | Mar 17, 2025 | March 19, 2025, 4:47 p.m. |
Porter James Richard
President and CEO
|
Sale | 601 | Mar 17, 2025 | March 19, 2025, 4:47 p.m. |
Noci Darlene
Chief Development Officer
|
Sale | 4306 | Mar 06, 2025 | March 10, 2025, 4:48 p.m. |
Noci Darlene
Chief Development Officer
|
Sale | 2900 | Mar 07, 2025 | March 10, 2025, 4:48 p.m. |
Noci Darlene
Chief Development Officer
|
Sale | 22016 | Mar 06, 2025 | March 10, 2025, 4:48 p.m. |
Noci Darlene
Chief Development Officer
|
Sale | 3678 | Mar 06, 2025 | March 10, 2025, 4:48 p.m. |
Noci Darlene
Chief Development Officer
|
Sale | 1100 | Mar 07, 2025 | March 10, 2025, 4:48 p.m. |
Shair Matthew
|
Sale | 316 | Feb 24, 2025 | Feb. 25, 2025, 5:49 p.m. |
Shair Matthew
|
Sale | 1382 | Feb 24, 2025 | Feb. 25, 2025, 5:49 p.m. |
Shair Matthew
|
Sale | 302 | Feb 24, 2025 | Feb. 25, 2025, 5:49 p.m. |
Porter James Richard
President and CEO
|
Sale | 26200 | Feb 18, 2025 | Feb. 20, 2025, 5:57 p.m. |
Porter James Richard
President and CEO
|
Sale | 800 | Feb 18, 2025 | Feb. 20, 2025, 5:57 p.m. |
Shair Matthew
|
Sale | 1040 | Jan 27, 2025 | Jan. 29, 2025, 5:45 p.m. |
Shair Matthew
|
Sale | 234 | Jan 27, 2025 | Jan. 29, 2025, 5:45 p.m. |
Shair Matthew
|
Sale | 618 | Jan 27, 2025 | Jan. 29, 2025, 5:45 p.m. |
Shair Matthew
|
Sale | 108 | Jan 27, 2025 | Jan. 29, 2025, 5:45 p.m. |
Porter James Richard
President and CEO
|
Sale | 5493 | Jan 15, 2025 | Jan. 17, 2025, 5:43 p.m. |
Porter James Richard
President and CEO
|
Sale | 9358 | Jan 15, 2025 | Jan. 17, 2025, 5:43 p.m. |
Porter James Richard
President and CEO
|
Sale | 5842 | Jan 15, 2025 | Jan. 17, 2025, 5:43 p.m. |
Porter James Richard
President and CEO
|
Sale | 6307 | Jan 15, 2025 | Jan. 17, 2025, 5:43 p.m. |
Pelish Henry E.
Chief Scientific Officer
|
Sale | 1343 | Jan 06, 2025 | Jan. 8, 2025, 6:05 p.m. |
Pelish Henry E.
Chief Scientific Officer
|
Sale | 428 | Jan 06, 2025 | Jan. 8, 2025, 6:05 p.m. |
Pelish Henry E.
Chief Scientific Officer
|
Sale | 712 | Jan 06, 2025 | Jan. 8, 2025, 6:05 p.m. |
Noci Darlene
Chief Development Officer
|
Sale | 2173 | Jan 06, 2025 | Jan. 8, 2025, 5:56 p.m. |
Noci Darlene
Chief Development Officer
|
Sale | 691 | Jan 06, 2025 | Jan. 8, 2025, 5:56 p.m. |
Noci Darlene
Chief Development Officer
|
Sale | 1152 | Jan 06, 2025 | Jan. 8, 2025, 5:56 p.m. |
Miller Deborah Ann
Chief Legal Officer
|
Sale | 510 | Jan 06, 2025 | Jan. 8, 2025, 5:53 p.m. |
Miller Deborah Ann
Chief Legal Officer
|
Sale | 850 | Jan 06, 2025 | Jan. 8, 2025, 5:53 p.m. |
Miller Deborah Ann
Chief Legal Officer
|
Sale | 1604 | Jan 06, 2025 | Jan. 8, 2025, 5:53 p.m. |
Turner Christopher Durant
Chief Medical Officer
|
Sale | 2173 | Jan 06, 2025 | Jan. 8, 2025, 5:50 p.m. |
Turner Christopher Durant
Chief Medical Officer
|
Sale | 691 | Jan 06, 2025 | Jan. 8, 2025, 5:50 p.m. |
Turner Christopher Durant
Chief Medical Officer
|
Sale | 1152 | Jan 06, 2025 | Jan. 8, 2025, 5:50 p.m. |
Balcom Alexandra
Chief Financial Officer
|
Sale | 2173 | Jan 06, 2025 | Jan. 8, 2025, 5:48 p.m. |
Balcom Alexandra
Chief Financial Officer
|
Sale | 691 | Jan 06, 2025 | Jan. 8, 2025, 5:48 p.m. |
Balcom Alexandra
Chief Financial Officer
|
Sale | 1152 | Jan 06, 2025 | Jan. 8, 2025, 5:48 p.m. |
Porter James Richard
President and CEO
|
Sale | 9360 | Jan 06, 2025 | Jan. 8, 2025, 5:45 p.m. |
Porter James Richard
President and CEO
|
Sale | 2979 | Jan 06, 2025 | Jan. 8, 2025, 5:45 p.m. |
Porter James Richard
President and CEO
|
Sale | 4962 | Jan 06, 2025 | Jan. 8, 2025, 5:45 p.m. |
Shair Matthew
|
Sale | 1409 | Dec 23, 2024 | Dec. 26, 2024, 5:49 p.m. |
Shair Matthew
|
Sale | 591 | Dec 23, 2024 | Dec. 26, 2024, 5:49 p.m. |
Porter James Richard
President and CEO
|
Sale | 8031 | Dec 16, 2024 | Dec. 18, 2024, 5:49 p.m. |
Porter James Richard
President and CEO
|
Sale | 18969 | Dec 16, 2024 | Dec. 18, 2024, 5:49 p.m. |
Hack Andrew A. F.
|
Sale | 1250000 | Dec 11, 2024 | Dec. 13, 2024, 5:30 p.m. |